KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 118 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.60 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $432,000 | -30.0% | 22,537 | -78.1% | 0.02% | -40.0% |
| Q2 2019 | $617,000 | +634.5% | 102,937 | +613.9% | 0.04% | +600.0% |
| Q1 2019 | $84,000 | -79.6% | 14,418 | -67.1% | 0.01% | -80.8% |
| Q4 2018 | $411,000 | -30.7% | 43,818 | +25.6% | 0.03% | -3.7% |
| Q3 2018 | $593,000 | -67.4% | 34,874 | -67.4% | 0.03% | -63.5% |
| Q2 2018 | $1,819,000 | +818.7% | 107,119 | +623.0% | 0.07% | +825.0% |
| Q1 2018 | $198,000 | -37.1% | 14,816 | -55.0% | 0.01% | -42.9% |
| Q4 2017 | $315,000 | +8.2% | 32,916 | +24.0% | 0.01% | -6.7% |
| Q3 2017 | $291,000 | -51.4% | 26,552 | -60.5% | 0.02% | -44.4% |
| Q1 2016 | $599,000 | -41.2% | 67,170 | -12.7% | 0.03% | -43.8% |
| Q4 2015 | $1,019,000 | -28.9% | 76,950 | -43.5% | 0.05% | -9.4% |
| Q3 2015 | $1,433,000 | +184.9% | 136,109 | +727.1% | 0.05% | +211.8% |
| Q1 2015 | $503,000 | +6.8% | 16,457 | +7.8% | 0.02% | -32.0% |
| Q1 2014 | $471,000 | – | 15,270 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,180,700 | $137,941,000 | 10.27% |
| Palo Alto Investors LP | 4,299,901 | $82,601,000 | 6.92% |
| Fairmount Funds Management LLC | 562,351 | $10,803,000 | 6.55% |
| Avoro Capital Advisors LLC | 7,000,000 | $134,470,000 | 4.54% |
| Pinz Capital Management, LP | 8,820 | $1,694,000 | 4.44% |
| Birchview Capital, LP | 148,000 | $2,843,000 | 2.52% |
| Elk Creek Partners, LLC | 699,951 | $13,446,000 | 2.31% |
| Parkman Healthcare Partners LLC | 215,802 | $4,146,000 | 1.92% |
| EAM Global Investors LLC | 136,402 | $2,620,000 | 1.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 550,000 | $10,566,000 | 1.32% |